We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$165M |
| 2 |
Costco
COST
|
+$134M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$126M |
| 4 |
Johnson Controls International
JCI
|
+$121M |
| 5 |
3M
MMM
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
Marathon Petroleum
MPC
|
+$123M |
| 4 |
CenterPoint Energy
CNP
|
+$123M |
| 5 |
Under Armour
UAA
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Arista Networks
ANET
$227B
| $10.8M | 0.03% |
848,800
-232,000
| -21% | -$3.05M |
|
527
ScottsMiracle-Gro
SMG
$3.82B
| $10.6M | 0.03% |
+100,000
| New | +$10.2M |
|
528
Digital Realty Trust
DLR
$69.7B
| $10.6M | 0.03% |
88,500
+38,500
| +77% | +$4.74M |
|
|
MNRL
529
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $10.4M | 0.03% |
486,672
-60,000
| -11% | -$1.17M |
|
530
Federal Realty Investment Trust
FRT
$10.7B
| $10.4M | 0.03% |
80,800
-3,900
| -5% | -$518K |
|
|
MRNS
531
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $10.4M | 0.03% |
+1,200,000
| New | +$6.73M |
|
532
Northern Trust
NTRS
$33.3B
| $10.2M | 0.03% |
96,300
-166,700
| -63% | -$17.1M |
|
533
TechnipFMC
FTI
$28.1B
| $10.1M | 0.02% |
635,040
-31,181
| -5% | -$484K |
|
534
Western Alliance Bancorporation
WAL
$8.79B
| $10.1M | 0.02% |
177,000
-33,000
| -16% | -$1.69M |
|
535
CONMED
CNMD
$1.39B
| $10.1M | 0.02% |
90,000
-55,000
| -38% | -$5.86M |
|
|
DISH
536
DELISTED
DISH Network Corp.
DISH
| $9.96M | 0.02% |
280,732
-8,207
| -3% | -$284K |
|
537
F5
FFIV
$22.9B
| $9.89M | 0.02% |
70,800
-900
| -1% | -$127K |
|
|
BLU
538
DELISTED
BELLUS Health Inc.
BLU
| $9.88M | 0.02% |
1,300,000
| – | – |
|
|
CLLS
539
Cellectis
CLLS
$277M
| $9.84M | 0.02% |
575,000
| – | – |
|
540
Zions Bancorporation
ZION
$10.2B
| $9.84M | 0.02% |
189,486
-9,400
| -5% | -$456K |
|
541
Campbell Soup
CPB
$6.55B
| $9.67M | 0.02% |
195,646
-9,300
| -5% | -$441K |
|
542
Kimco Realty
KIM
$17.2B
| $9.67M | 0.02% |
466,763
-23,400
| -5% | -$491K |
|
543
Bank of N.T. Butterfield & Son
NTB
$2.43B
| $9.63M | 0.02% |
+260,000
| New | +$8.68M |
|
544
Milestone Pharmaceuticals
MIST
$138M
| $9.61M | 0.02% |
600,000
+100,000
| +20% | +$1.77M |
|
545
MeiraGTx Holdings
MGTX
$1.09B
| $9.51M | 0.02% |
475,000
| – | – |
|
546
Avery Dennison
AVY
$13B
| $9.45M | 0.02% |
72,225
-229,600
| -76% | -$29M |
|
547
LKQ Corp
LKQ
$5.68B
| $9.42M | 0.02% |
263,800
-17,000
| -6% | -$577K |
|
548
Visteon
VC
$2.79B
| $9.32M | 0.02% |
107,617
+54,217
| +102% | +$4.83M |
|
549
Inspire Medical Systems
INSP
$1.45B
| $9.28M | 0.02% |
+125,000
| New | +$8.03M |
|
550
Inogen
INGN
$175M
| $9.22M | 0.02% |
+135,000
| New | +$8.47M |
|
Similar funds
Adage Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.
- Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
- Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
- Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
- Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
- Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
- Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.